title: Reproduction rates after cytotoxic therapy.
authors.forename: Birgit
authors.initials: B
authors.lastname: Mispelaere
authors.forename: Evelyn
authors.initials: E
authors.lastname: Van de Werf
authors.forename: Thomas
authors.initials: T
authors.lastname: D'Hooghe
authors.forename: Anne-Sophie
authors.initials: AS
authors.lastname: Dieudonné
authors.forename: Frederic
authors.initials: F
authors.lastname: Amant
authors.forename: Tim
authors.initials: T
authors.lastname: Van Mieghem
authors.forename: Patrick
authors.initials: P
authors.lastname: Neven
authors.forename: Robert
authors.initials: R
authors.lastname: Paridaens
authors.forename: Hans
authors.initials: H
authors.lastname: Wildiers
mesh_terms: D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D005298:Fertility / Q000187:drug effects; D006801:Humans; D007247:Infertility, Female / Q000139:chemically induced* / Q000523:psychology; D008223:Lymphoma / Q000188:drug therapy*; D008597:Menstrual Cycle; D009664:Norway; D011247:Pregnancy / Q000523:psychology; D018873:Pregnancy Rate; D011795:Surveys and Questionnaires; D055815:Young Adult
chemical_list: D000970:Antineoplastic Agents